Evaluation of warm compresses and topical cyclosporine treatment in meibomian gland dysfunction by confocal scanning laser microscopy
- 22 October 2022
- journal article
- research article
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 33 (2) , 881-889
Abstract
Purpose: The aim of our study is to confirm the utility of warm compresses (WC) and artificial tears (AT) in meibomian gland dysfunction (MGD) management and to understand if its association with topical cyclosporine A (CsA) improves outcomes. Methods: Patients with diagnosis of MGD-related dry eye were evaluated. In this prospective, randomized, double-masked study, patients were randomized in two treatments: AT plus WC (group A), and AT plus WC plus CsA 0.05% ophthalmic emulsion (group B). At baseline and at 1, 3, and 6 months, Ocular Surface Disease Index (OSDI) questionnaire was completed, and tear evaluation (BUT, Schirmer and osmolarity test), ocular surface evaluation (fluorescein and lissamine green staining), clinical (Shimazaki grading) and in vivo confocal microscopy (IVCM) evaluation of rete ridges (RRs) were performed. Results: A total of 40 eyes, 20 in each group, completed the study. Analysis of OSDI, tear test, ocular surface evaluation and clinical grading of MG showed significant improvement at 6 months, whereas no difference was found between the two groups at 6 months. The analysis of IVCM showed significant improvement in both groups, but significantly better results in group B were found compared to group A at 6 months. Conclusion: WC performed 3 times daily during the 1st month and once daily afterwards, in addition to AT, were useful to manage the obstruction of MG and related signs and symptoms. Additional effects of CsA were visible in IVCM only at 6 months. IVCM is an effective tool to monitor treatments in MGD.Keywords
This publication has 37 references indexed in Scilit:
- Emerging treatment options for meibomian gland dysfunctionClinical Ophthalmology, 2013
- In Vivo Confocal Microscopy of Meibomian Glands in Contact Lens WearersInvestigative Ophthalmology & Visual Science, 2011
- The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland DysfunctionInvestigative Ophthalmology & Visual Science, 2011
- The International Workshop on Meibomian Gland Dysfunction: Report of the Diagnosis SubcommitteeInvestigative Ophthalmology & Visual Science, 2011
- The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on the Epidemiology of, and Associated Risk Factors for, MGDInvestigative Ophthalmology & Visual Science, 2011
- The International Workshop on Meibomian Gland Dysfunction: Executive SummaryInvestigative Ophthalmology & Visual Science, 2011
- Corneal and Conjunctival Sensitivity in Patients With Dry Eye: The Effect of Topical Cyclosporine TherapyCornea, 2010
- Efficacy of Commercially Available Topical Cyclosporine A 0.05% in the Treatment of Meibomian Gland DysfunctionCornea, 2006
- Efficacy of Topical Cyclosporin 0.05% in the Treatment of Posterior BlepharitisJournal of Ocular Pharmacology and Therapeutics, 2006
- Distribution of Cyclosporin A in the Cornea After Topical or Oral AdministrationJournal of Ocular Pharmacology and Therapeutics, 2002